Review of bupivacaine use in treatment of strabismus

This review aimed to assess the applications of bupivacaine (B) in the non-surgical treatment of strabismus in human and animal studies. Animal studies show that singly-innervated fibres with low concentrations of mitochondria and developed sarcoplasmic reticulum are more affected by...

Use of botulinum toxin A in the treatment of intermittent exotropia

In this prospective cohort study, the authors aimed to evaluate the efficiency of botulinum toxin A (BTA) injection in the treatment of intermittent exotropia (IXT) and examine factors affecting treatment outcomes. Seventy-four patients diagnosed with any type of IXT were...

BT outcomes for accommodative esotropia

The purpose of this study was to study the effect of Botulinum Toxin (BT) in refractive and non-refractive accommodative esotropia unresponsive to glasses and poor compliance with glasses. This was a retrospective study of 114 patients who had BT for...

Long-term use of botulinum toxin for hemifacial spasm and blepharospasm

The authors conducted a retrospective review of clinical / procedure documentation for consecutive blepharospasm (BEB) and hemifacial spasm (HFS) patients undergoing treatment with onabotulinum toxin A (Botox) in one clinic setting over the past 20 years. They report on the...

BT outcome for CP and ET

The authors evaluate the clinical outcome of botulinum toxin (BT) injection in the correction of esotropia in 44 patients with cerebral palsy (CP). BT was injected under general anaesthesia without EMG guidance. Of the children, 47.7% were male and mean...

BT for intermittent exotropia

This study aimed to evaluate the effect of botulinum toxin (BT) on the amount of deviation and fusional control state of intermittent exotropia. Twenty-one patients (five male and 16 female) aged five to 18 years with progression of exotropia were...